vaccine

These days, Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are swimming in real money and they have COVID-19 to thank. Since the beginning of April, Moderna and BioNTech (NASDAQ: BNTX) saw their shares go up about 80% and 100%, respectively. Much of that climb has been on the assumption...

Novavax, Inc. (NASDAQ: NVAX) shares tumbled lower Wednesday after retail traders were able to push the stock lower. Vaccine stocks were very volatile today, and many are trading lower amid possible profit-taking as there are COVID-19 delta variant concerns. The stock was trending throughout the day...

Moderna, Inc.'s (NASDAQ: MRNA) COVID-19 vaccine should soon find its way into India, one of the countries worst affected by the second wave of the pandemic. What Happened: India's drug regulator, the Drugs Controller General of India, has approved the importation of Moderna's...

The U.S. government has placed an order for an additional 200 million doses of mRNA-1273, Moderna, Inc.'s (NASDAQ: MRNA) vaccine against the novel coronavirus, the company said in a statement Wednesday.  The new agreement also carries an option to buy other COVID-19 vaccine...

It was "better late than never" for Novavax, Inc. (NASDAQ: NVAX), as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus. Here's a comparative perspective...

Part of the Biden administration's new strategy on allocating COVID-19 vaccines targets rural communities, which have some of the lowest vaccination rates in the country. In line with that goal as well as the imperative to speed vaccines to remote areas worldwide, major carriers have adopted...

Novavax, Inc. (NVAX) announced positive results from the animal study of its combo vaccine for influenza and COVID-19. The positive news however did little to stem the sell-off in shares that began in late April. What Happened: Gaithersburg, Maryland-based Novavax said data from a...

The COVID-19 pandemic is continuing to rage unabated. Just as countries across the globe were coming online from a protracted lockdown, the second and third wave of the pandemic is threatening to derail hopes of a return to a more normal way of life.  It's against this backdrop that...

While some people are scrambling to get the COVID-19 vaccine, some are hesitating for various reasons. But a family physician in Buffalo, New York, is doing his best to get as many people vaccinated as possible — even offering up a chance at winning a Tesla Inc (NASDAQ: TSLA) Model 3....

Johnson & Johnson (NYSE: JNJ) got a reprieve after the Food and Drug Administration and the Centers for Disease Control revoked their earlier recommendation to pause the use of its COVID-19 vaccine. What Happened: The pause regarding the use of J&J's COVID-19 vaccine should be lifted...

On Tuesday, Johnson & Johnson (NYSE: JNJ) reported $100 million in first-quarter sales of its single shot Covid-19 vaccine that's on hold in the U.S. due to a rare and potentially life-threatening blood clotting disorder which has been also related to AstraZeneca (NASDAQ: AZN) vaccine which...

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) handed down a recommendation to pause the use of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine. In a joint audio press conference hosted by Acting FDA Commissioner Janet Woodcock,...

Novavax, Inc. (NASDAQ: NVAX) coronavirus vaccine candidate is inching closer to the final leg of clinical testing and could be approved soon after, contingent on the data.  However, the vaccine developer is facing trouble in stepping up production to achieve full potential. What...

The Food and Drug Administration and the Centers for Disease Control and Prevention are recommending a pause in the use of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine, the agencies said in a Tuesday statement, sending the drugmaker's stock lower in premarket trading....

Israel has been hailed for its success with its coronavirus vaccine rollout, claiming the honors of having the highest per-capita vaccine administration in the world. It's moving vigorously ahead with the target of getting 80% of the country's 9.2 million people vaccinated by May. Israel...